| abstract |
The present invention relates to compounds that can enter macrophages and methods of use thereof. The present invention further relates to compounds capable of modulating (eg inhibiting) the activity of a mammalian target of rapamycin (mTor), which can treat mTor related diseases, particularly related to mTor in macrophages, Not limited to). Relates to compounds. The present invention also relates to compounds capable of imaging mTor in a subject, particularly mTor in macrophages, but not limited thereto. [Selection] Figure 1 |